Research Reports

To access Ascendiant's recent equity research initiations, please click on the link below.  For current reports, or for reports on companies not shown, please contact Edward Woo, Director of Research, at or 949.259.4932.

Verb Technology Company, Inc. (Nasdaq: VERB) - initiation

PAVmed Inc. (NasdaqGS: PAVM) - initiation

Atossa Therapeutics, Inc. (NasdaqCM: ATOS) - initiation

Phunware, Inc. (NasdaqGS: PHUN) - initiation

IMAC Holdings, Inc. (NasdaqGS: IMAC) - initiation

SINTX Technologies, Inc. (NasdaqCM: SINT) - initiation

Myomo, Inc. (NYSE American: MYO) - initiation

BioHiTech Global, Inc. (NasdaqCM: BHTG) - initiation

Nemaura Medical, Inc. (NasdaqCM: NMRD) - initiation

Daxor Corporation (NYSE American: DXR) - initiation

Monaker Group, Inc. (NasdaqCM: MKGI) - initiation

Outlook Therapeutics, Inc. (NasdaqCM: OTLK) - initiation

ENDRA Life Sciences, Inc. (NasdaqCM: NDRA) - initiation

FlexShopper, Inc. (NasdaqCM: FPAY) - initiation

Oragenics, Inc. (NYSE American: OGEN) - initiation

Hemispherx Biopharma, Inc. (NYSE American: HEB) - initiation 

Summit Wireless Technologies, Inc. (NasdaqCM: WISA) - initiation

ADOMANI, Inc. (NasdaqCM: ADOM) - initiation

MusclePharm Corporation (OTC: MSLP) - initiation

ENSERVCO Corporation (NYSE American: ENSV) - initiation

IsoRay, Inc. (NYSE American: ISR) - initiation

Aemetis, Inc. (NasdaqCM: AMTX) - initiation

ARCA biopharma, Inc. (NasdaqCM: ABIO) - initiation

Novus Therapeutics, Inc. (NasdaqCM: NVUS) - initiation

LRAD Corporation (NasdaqCM: LRAD) - initiation